Prostemics Co. Ltd (KQ:203690) — Market Cap & Net Worth
Market Cap & Net Worth: Prostemics Co. Ltd (203690)
Prostemics Co. Ltd (KQ:203690) has a market capitalization of $1.88 Million (₩2.78 Billion) as of October 13, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #30197 globally and #2101 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Prostemics Co. Ltd's stock price ₩139.00 by its total outstanding shares 19989711 (19.99 Million).
Prostemics Co. Ltd Market Cap History: 2015 to 2026
Prostemics Co. Ltd's market capitalization history from 2015 to 2026. Data shows change from $286.51 Million to $1.88 Million (-39.10% CAGR). Check current stock price of Prostemics Co. Ltd for real-time trading data and today's change.
Index Memberships
Prostemics Co. Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$256.95 Billion | 0.00% | #1149 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$256.95 Billion | 0.00% | #1149 of 1384 |
Weight: Prostemics Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Prostemics Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Prostemics Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see Prostemics Co. Ltd (203690) cash conversion ratio for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
0.00x
Prostemics Co. Ltd's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $285.50 Million | $14.16 Billion | $4.31 Billion | 0.02x | 0.07x |
| 2017 | $484.30 Million | $6.56 Billion | -$3.16 Billion | 0.07x | N/A |
| 2018 | $367.12 Million | $4.72 Billion | -$6.30 Billion | 0.08x | N/A |
| 2019 | $236.39 Million | $7.13 Billion | -$3.18 Billion | 0.03x | N/A |
| 2020 | $298.03 Million | $20.73 Billion | -$7.27 Billion | 0.01x | N/A |
| 2021 | $186.61 Million | $32.53 Billion | -$7.24 Billion | 0.01x | N/A |
| 2022 | $66.92 Million | $26.58 Billion | -$5.56 Billion | 0.00x | N/A |
| 2023 | $137.63 Million | $37.25 Billion | -$24.24 Billion | 0.00x | N/A |
| 2024 | $75.86 Million | $33.23 Billion | -$9.43 Billion | 0.00x | N/A |
| 2025 | $59.94 Million | $16.08 Billion | -$11.80 Billion | 0.00x | N/A |
Competitor Companies of 203690 by Market Capitalization
Companies near Prostemics Co. Ltd in the global market cap rankings as of October 13, 2026. See Prostemics Co. Ltd (203690) net asset quality to understand what proportion of total assets are financed by equity.
Key companies related to Prostemics Co. Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #185 globally with a market cap of $129.29 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #367 globally with a market cap of $75.50 Billion USD.
- CSL Ltd (AU:CSL): Ranked #448 globally with a market cap of $63.11 Billion USD ( AU$89.19 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #509 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #185 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $129.29 Billion | $510.08 |
| #367 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $75.50 Billion | $746.54 |
| #448 | CSL Ltd | AU:CSL | $63.11 Billion | AU$183.84 |
| #509 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $225.00 |
Prostemics Co. Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Prostemics Co. Ltd's market cap moved from $286.51 Million to $ 1.88 Million, with a yearly change of -39.10%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩1.88 Million | -96.86% |
| 2025 | ₩59.94 Million | -20.98% |
| 2024 | ₩75.86 Million | -44.88% |
| 2023 | ₩137.63 Million | +105.67% |
| 2022 | ₩66.92 Million | -64.14% |
| 2021 | ₩186.61 Million | -37.39% |
| 2020 | ₩298.03 Million | +26.07% |
| 2019 | ₩236.39 Million | -35.61% |
| 2018 | ₩367.12 Million | -24.20% |
| 2017 | ₩484.30 Million | +69.63% |
| 2016 | ₩285.50 Million | -0.35% |
| 2015 | ₩286.51 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 12th, 2026 the market cap of Prostemics Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.88 Million USD |
| MoneyControl | $1.88 Million USD |
| MarketWatch | $1.88 Million USD |
| marketcap.company | $1.88 Million USD |
| Reuters | $1.88 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Prostemics Co. Ltd
Ark Solutions Inc. offers hygiene products in South Korea. The company offers wet wipes, adult diapers, and towels. The company also involved in dismantling and recycling vehicles. In addition, it engages in maritime logistics infrastructure business; and cosmetics wholesale and retail business. The company was formerly known as Sphere Power Inc. and changed its name to Ark Solutions Inc. in Nove… Read more